[{"data":1,"prerenderedAt":132},["ShallowReactive",2],{"drug-orphenadrine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":35,"contraindications":54,"warnings":64,"renal":65,"monitoring":66,"interactions":67,"review":68,"examples":71,"atc":77,"iran":79,"links":91,"populations":108,"usApproval":127},"orphenadrine",1,{"fa":7,"en":8},"اورفنادرین","Orphenadrine","musculoskeletal",{"fa":11,"en":12},"شل‌کننده عضلانی با اثر مرکزی","Centrally acting muscle relaxant",[14],{"name":15,"market":16},"Norflex","US",[18,7,19],"norflex","ارفنادرین",[21],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"er-100","tablet","oral","100 mg extended-release tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},100,"mg",false,[16],[32],{"source":33,"section":34},"fda-orphenadrine","How Supplied",[36],{"id":37,"disease":38,"label":39,"population":42,"type":46,"unit":28,"dose":47,"refs":49},"spasm","muscle-spasm",{"fa":40,"en":41},"درد عضلانی-اسکلتی حاد (کمکی) — یک قرص صبح و یک قرص عصر","Acute painful musculoskeletal conditions (adjunct) — one tablet morning and evening",{"minAge":43},{"value":44,"unit":45},18,"year","fixed",{"perDose":27,"dosesPerDay":48},2,[50,52],{"source":33,"section":51},"Dosage and Administration",{"source":33,"section":53},"Indications and Usage",[55],{"id":56,"severity":57,"text":58,"refs":61},"ci","block",{"fa":59,"en":60},"گلوکوم؛ انسداد پیلور یا دوازدهه؛ زخم پپتیک تنگ‌کننده؛ هیپرتروفی پروستات یا انسداد گردن مثانه؛ آشالازی؛ میاستنی گراویس؛ حساسیت.","Glaucoma; pyloric or duodenal obstruction; stenosing peptic ulcer; prostatic hypertrophy or bladder-neck obstruction; cardiospasm (megaoesophagus); myasthenia gravis; hypersensitivity.",[62],{"source":33,"section":63},"Contraindications",[],[],[],[],{"status":69,"reviewer":70,"date":70},"unverified",null,[72],{"regimen":37,"formulation":22,"input":73,"expect":76},{"ageYears":74,"weightKg":75},40,70,{"perDose":27,"tabletsPerDoseRounded":5},[78],"M03BC01",{"status":80,"forms":81,"refs":86},"registered",[82],{"code":83,"en":84,"fa":85},"12580","ORPHENADRINE HCL 50MG  CAP","کپسول ارفنادرین هیدروکلراید ۵۰ میلی‌گرم",[87],{"source":88,"section":89,"url":90},"darooyab-generic","G-905\u002FOrphenadrine","https:\u002F\u002Fwww.darooyab.ir\u002FG-905\u002FOrphenadrine",[92,96,100,103,106],{"kind":93,"url":94,"label":95},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=040284","ANDA040284",{"kind":97,"url":98,"label":99},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=7b76c8a7-dd0c-481c-8299-26dfd38ce066","FDA Orphenadrine ER",{"kind":101,"url":102,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682162.html",{"kind":104,"url":105,"label":78},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=M03BC01",{"kind":107,"url":90,"label":8},"darooyab",{"pregnancy":109,"pediatric":118},{"level":110,"text":111,"quote":114,"refs":115},"caution",{"fa":112,"en":113},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Pregnancy Category C Animal reproduction studies have not been conducted with orphenadrine.",[116],{"source":33,"section":117},"Pregnancy",{"level":119,"text":120,"quote":123,"refs":124},"not-established",{"fa":121,"en":122},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness in pediatric patients have not been established.",[125],{"source":33,"section":126},"Pediatric Use",{"kind":128,"refs":129,"id":95},"ANDA",[130],{"source":33,"section":131},"SPL approval \u002F marketing category",1792156189899]